ING5 suppresses breast cancer progression and is regulated by miR-24
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ING5 suppresses breast cancer progression and is regulated by miR-24
Authors
Keywords
ING5, microRNA, miR-24, Breast cancer, Proliferation, Invasion, Apoptosis
Journal
Molecular Cancer
Volume 16, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-05-10
DOI
10.1186/s12943-017-0658-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- miR-19a promotes colorectal cancer proliferation and migration by targeting TIA1
- (2017) Yanqing Liu et al. Molecular Cancer
- Onco-miR-24 regulates cell growth and apoptosis by targeting BCL2L11 in gastric cancer
- (2016) Haiyang Zhang et al. Protein & Cell
- Upregulation of miR-24 promotes cell proliferation by targeting NAIF1 in non-small cell lung cancer
- (2015) Guibin Zhao et al. TUMOR BIOLOGY
- ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression
- (2015) Wen-feng Gou et al. Oncotarget
- ING5 inhibits cancer aggressiveness via preventing EMT and is a potential prognostic biomarker for lung cancer
- (2015) Feng Zhang et al. Oncotarget
- Oncogenic MicroRNAs: miR-155, miR-19a, miR-181b, and miR-24 enable monitoring of early breast cancer in serum
- (2014) Marek Sochor et al. BMC CANCER
- MicroRNA miR-24 enhances tumor invasion and metastasis by targeting PTPN9 and PTPRF to promote EGF signaling
- (2013) W. W. Du et al. JOURNAL OF CELL SCIENCE
- MiR-24 Promotes the Survival of Hematopoietic Cells
- (2013) Tan Nguyen et al. PLoS One
- ING1 and 5-Azacytidine Act Synergistically to Block Breast Cancer Cell Growth
- (2012) Satbir Thakur et al. PLoS One
- Regulation of p53 by ING family members in suppression of tumor initiation and progression
- (2011) Seyed Mehdi Jafarnejad et al. CANCER AND METASTASIS REVIEWS
- Genome-wide functional screen identifies a compendium of genes affecting sensitivity to tamoxifen
- (2011) A. M. Mendes-Pereira et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The nuclear to cytoplasmic shift of ING5 protein during colorectal carcinogenesis with their distinct links to pathologic behaviors of carcinomas☆
- (2010) Hua-chuan Zheng et al. HUMAN PATHOLOGY
- The altered expression of ING5 protein is involved in gastric carcinogenesis and subsequent progression☆
- (2010) Ya-nan Xing et al. HUMAN PATHOLOGY
- Tumor-specific mutation and downregulation of ING5 detected in oral squamous cell carcinoma
- (2010) Beyhan Cengiz et al. INTERNATIONAL JOURNAL OF CANCER
- Decreased nuclear expression and increased cytoplasmic expression of ING5 may be linked to tumorigenesis and progression in human head and neck squamous cell carcinoma
- (2010) Xiaohan Li et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- miR-24 up-regulation in oral carcinoma: Positive association from clinical and in vitro analysis
- (2010) Shu-Chun Lin et al. ORAL ONCOLOGY
- Differential regulation of microRNA stability
- (2010) S. Bail et al. RNA
- Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model
- (2009) Janaiah Kota et al. CELL
- The Inhibitor of Growth (ING) Gene Family: Potential Role in Cancer Therapy
- (2008) Mehmet Gunduz et al. CURRENT CANCER DRUG TARGETS
- Not miR-ly small RNAs: Big potential for microRNAs in therapy
- (2008) Tara M. Love et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The ING gene family in the regulation of cell growth and tumorigenesis
- (2008) Andrew H. Coles et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The utility of LNA in microRNA-based cancer diagnostics and therapeutics
- (2008) Jan Stenvang et al. SEMINARS IN CANCER BIOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started